264 related articles for article (PubMed ID: 19549892)
21. Prostaglandin E2 mediates phosphorylation and down-regulation of the tuberous sclerosis-2 tumor suppressor (tuberin) in human endometrial adenocarcinoma cells via the Akt signaling pathway.
Sales KJ; Battersby S; Williams AR; Anderson RA; Jabbour HN
J Clin Endocrinol Metab; 2004 Dec; 89(12):6112-8. PubMed ID: 15579767
[TBL] [Abstract][Full Text] [Related]
22. CXCR2-driven ovarian cancer progression involves upregulation of proinflammatory chemokines by potentiating NF-κB activation via EGFR-transactivated Akt signaling.
Dong YL; Kabir SM; Lee ES; Son DS
PLoS One; 2013; 8(12):e83789. PubMed ID: 24376747
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia and prostaglandin E receptor 4 signalling pathways synergise to promote endometrial adenocarcinoma cell proliferation and tumour growth.
Catalano RD; Wilson MR; Boddy SC; McKinlay AT; Sales KJ; Jabbour HN
PLoS One; 2011 May; 6(5):e19209. PubMed ID: 21589857
[TBL] [Abstract][Full Text] [Related]
24. Endothelin-1 induces neutrophil recruitment in adaptive inflammation via TNFα and CXCL1/CXCR2 in mice.
Zarpelon AC; Pinto LG; Cunha TM; Vieira SM; Carregaro V; Souza GR; Silva JS; Ferreira SH; Cunha FQ; Verri WA
Can J Physiol Pharmacol; 2012 Feb; 90(2):187-99. PubMed ID: 22320712
[TBL] [Abstract][Full Text] [Related]
25. Seminal plasma and prostaglandin E2 up-regulate fibroblast growth factor 2 expression in endometrial adenocarcinoma cells via E-series prostanoid-2 receptor-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase pathway.
Battersby S; Sales KJ; Williams AR; Anderson RA; Gardner S; Jabbour HN
Hum Reprod; 2007 Jan; 22(1):36-44. PubMed ID: 16905765
[TBL] [Abstract][Full Text] [Related]
26. Epithelial Hypoxia-Inducible Factor 2α Facilitates the Progression of Colon Tumors through Recruiting Neutrophils.
Triner D; Xue X; Schwartz AJ; Jung I; Colacino JA; Shah YM
Mol Cell Biol; 2017 Mar; 37(5):. PubMed ID: 27956697
[TBL] [Abstract][Full Text] [Related]
27. CXCR2 antagonists block the N-Ac-PGP-induced neutrophil influx in the airways of mice, but not the production of the chemokine CXCL1.
Braber S; Overbeek SA; Koelink PJ; Henricks PA; Zaman GJ; Garssen J; Kraneveld AD; Folkerts G
Eur J Pharmacol; 2011 Oct; 668(3):443-9. PubMed ID: 21458445
[TBL] [Abstract][Full Text] [Related]
28. Rapid accumulation of polymorphonuclear neutrophils in the Corpus luteum during prostaglandin F(2α)-induced luteolysis in the cow.
Shirasuna K; Jiemtaweeboon S; Raddatz S; Nitta A; Schuberth HJ; Bollwein H; Shimizu T; Miyamoto A
PLoS One; 2012; 7(1):e29054. PubMed ID: 22235260
[TBL] [Abstract][Full Text] [Related]
29. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma.
Li L; Xu L; Yan J; Zhen ZJ; Ji Y; Liu CQ; Lau WY; Zheng L; Xu J
J Exp Clin Cancer Res; 2015 Oct; 34():129. PubMed ID: 26503598
[TBL] [Abstract][Full Text] [Related]
30. Differential internalization of the prostaglandin f(2alpha) receptor isoforms: role of protein kinase C and clathrin.
Srinivasan D; Fujino H; Regan JW
J Pharmacol Exp Ther; 2002 Jul; 302(1):219-24. PubMed ID: 12065720
[TBL] [Abstract][Full Text] [Related]
31. Prostaglandin F(2alpha) stimulates MEK-ERK signalling but decreases the expression of alkaline phosphatase in dental pulp cells.
Chang MC; Chen YJ; Lee MY; Lin LD; Wang TM; Chan CP; Tsai YL; Wang CY; Lin BR; Jeng JH
Int Endod J; 2010 Jun; 43(6):461-8. PubMed ID: 20536573
[TBL] [Abstract][Full Text] [Related]
32. FP prostanoid receptor-mediated induction of the expression of early growth response factor-1 by activation of a Ras/Raf/mitogen-activated protein kinase signaling cascade.
Xu W; Chou CL; Sun H; Fujino H; Chen QM; Regan JW
Mol Pharmacol; 2008 Jan; 73(1):111-8. PubMed ID: 17911534
[TBL] [Abstract][Full Text] [Related]
33. The chemokine CXCL1 and its receptor CXCR2 contribute to chronic stress-induced depression in mice.
Chai HH; Fu XC; Ma L; Sun HT; Chen GZ; Song MY; Chen WX; Chen YS; Tan MX; Guo YW; Li SP
FASEB J; 2019 Aug; 33(8):8853-8864. PubMed ID: 31034777
[TBL] [Abstract][Full Text] [Related]
34. Expression and functional evidence of the prostaglandin F2alpha receptor mediating contraction in human umbilical vein.
Errasti AE; del-Rey G; Cesio CE; Souza G; Nowak W; Pelorosso FG; Daray FM; Rothlin RP
Eur J Pharmacol; 2009 May; 610(1-3):68-74. PubMed ID: 19289115
[TBL] [Abstract][Full Text] [Related]
35. Effect of conceptus on expression of prostaglandin F2α receptor in the porcine endometrium.
Kaczynski P; Waclawik A
Theriogenology; 2013 Mar; 79(5):784-90. PubMed ID: 23321275
[TBL] [Abstract][Full Text] [Related]
36. PGF(2alpha), a prostanoid released by endothelial cells activated by hypoxia, is a chemoattractant candidate for neutrophil recruitment.
Arnould T; Thibaut-Vercruyssen R; Bouaziz N; Dieu M; Remacle J; Michiels C
Am J Pathol; 2001 Jul; 159(1):345-57. PubMed ID: 11438482
[TBL] [Abstract][Full Text] [Related]
37. miR141-CXCL1-CXCR2 signaling-induced Treg recruitment regulates metastases and survival of non-small cell lung cancer.
Lv M; Xu Y; Tang R; Ren J; Shen S; Chen Y; Liu B; Hou Y; Wang T
Mol Cancer Ther; 2014 Dec; 13(12):3152-62. PubMed ID: 25349304
[TBL] [Abstract][Full Text] [Related]
38. Novel suppression mechanism operating in early phase of adipogenesis by positive feedback loop for enhancement of cyclooxygenase-2 expression through prostaglandin F2α receptor mediated activation of MEK/ERK-CREB cascade.
Ueno T; Fujimori K
FEBS J; 2011 Aug; 278(16):2901-12. PubMed ID: 21668646
[TBL] [Abstract][Full Text] [Related]
39. Activation of the human FP prostanoid receptor disrupts mitosis progression and generates aneuploidy and polyploidy.
Chen XB; Regan JW
Cell Mol Life Sci; 2006 Jan; 63(1):112-21. PubMed ID: 16378246
[TBL] [Abstract][Full Text] [Related]
40. Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compounds.
Woodward DF; Krauss AH; Chen J; Gil DW; Kedzie KM; Protzman CE; Shi L; Chen R; Krauss HA; Bogardus A; Dinh HT; Wheeler LA; Andrews SW; Burk RM; Gac T; Roof MB; Garst ME; Kaplan LJ; Sachs G; Pierce KL; Regan JW; Ross RA; Chan MF
Br J Pharmacol; 2000 Aug; 130(8):1933-43. PubMed ID: 10952685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
